Results 201 to 210 of about 213,365 (383)

Medication Management of Patients With Cancer Undergoing Surgery From Preadmission to Discharge: A Mixed‐Methods Systematic Review

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim(s) To identify and synthesise available evidence about regular medication management processes, from preadmission to discharge from hospital, in patients with cancer undergoing surgery. Design Mixed‐methods systematic review. Methods Studies published from inception of each database until February 2023 were screened, utilising four main ...
Mehrabifar Atefeh   +2 more
wiley   +1 more source

Discussion on the Operative and Conservative Treatment of Perforated Peptic Ulceration [PDF]

open access: bronze, 1951
D CHAMBERLAIN   +4 more
openalex   +1 more source

Assessing the Impact of an Integrated Community Care Program on Unplanned Hospital and Emergency Department Representations: Interrupted Time Series Analysis

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Background This study aimed to evaluate the impact of the Community Care Program, which was the amalgamation of three outreach services—post‐acute care, Residential In‐Reach, and the Hospital Admission Risk Program—into a single integrated care model.
Brendan Shannon   +6 more
wiley   +1 more source

Elevated amputation rates in COVID‐19 survivors: Insights from a large‐scale Japanese cohort study

open access: yesJournal of Diabetes Investigation, EarlyView.
COVID‐19 is associated with a long‐term increased risk of amputation, persisting for more than 2 years post infection. These findings highlight the need for vigilant vascular monitoring and early intervention to mitigate the long‐term complications of COVID‐19.
Daisuke Miyamori   +2 more
wiley   +1 more source

Does Seasonality Affect Peptic Ulcer Perforation? A Single-Center Retrospective Study. [PDF]

open access: yesMedicina (Kaunas)
Krajnović I   +4 more
europepmc   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy